Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab
Status:
Not yet recruiting
Trial end date:
2025-02-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness in the treatment of
recurrent glioblastoma with Cadonilimab combined with fractionated radiotherapy.
Phase:
Phase 1
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University